Nimbus Therapeutics pulls in $43 mln
Cambridge, Massachusetts-based biotech company Nimbus Therapeutics (formerly known as Nimbus Discovery) has closed $43 million in Series B funding. Pfizer Venture Investments and Lightstone Ventures led the round with participation from the company's previous backers that included Atlas Venture, SR One, Lilly Ventures and Bill Gates.
19 March 2015•3 mins read
